These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29095983)

  • 1. Progesterone Suppression of Luteinizing Hormone Pulse Frequency in Adolescent Girls With Hyperandrogenism: Effects of Metformin.
    Lundgren JA; Kim SH; Burt Solorzano CM; McCartney CR; Marshall JC
    J Clin Endocrinol Metab; 2018 Jan; 103(1):263-270. PubMed ID: 29095983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls--implications for regulation of pubertal maturation.
    Blank SK; McCartney CR; Chhabra S; Helm KD; Eagleson CA; Chang RJ; Marshall JC
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2360-6. PubMed ID: 19351732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids.
    Eagleson CA; Bellows AB; Hu K; Gingrich MB; Marshall JC
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5158-62. PubMed ID: 14602743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls.
    Chhabra S; McCartney CR; Yoo RY; Eagleson CA; Chang RJ; Marshall JC
    J Clin Endocrinol Metab; 2005 May; 90(5):2810-5. PubMed ID: 15728200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
    Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.
    Kolodziejczyk B; Duleba AJ; Spaczynski RZ; Pawelczyk L
    Fertil Steril; 2000 Jun; 73(6):1149-54. PubMed ID: 10856473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study.
    Pau CT; Keefe C; Duran J; Welt CK
    J Clin Endocrinol Metab; 2014 May; 99(5):1870-8. PubMed ID: 24606093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
    Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute progesterone feedback on gonadotropin secretion is not demonstrably altered in estradiol-pretreated women with polycystic ovary syndrome.
    Kim SH; Lundgren JA; Patrie JT; Burt Solorzano CM; McCartney CR
    Physiol Rep; 2022 Apr; 10(7):e15233. PubMed ID: 35384387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone has rapid positive feedback actions on LH release but fails to reduce LH pulse frequency within 12 h in estradiol-pretreated women.
    Hutchens EG; Ramsey KA; Howard LC; Abshire MY; Patrie JT; McCartney CR
    Physiol Rep; 2016 Aug; 4(16):. PubMed ID: 27535481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.
    Genazzani AD; Battaglia C; Malavasi B; Strucchi C; Tortolani F; Gamba O
    Fertil Steril; 2004 Jan; 81(1):114-9. PubMed ID: 14711553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.
    Ibáñez L; Valls C; Ferrer A; Marcos MV; Rodriguez-Hierro F; de Zegher F
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3595-8. PubMed ID: 11502783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Pastor CL; Griffin-Korf ML; Aloi JA; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated Episodic Luteinizing Hormone Release Accompanies Blunted Progesterone Regulation in PCOS-like Female Rhesus Monkeys (Macaca Mulatta) Exposed to Testosterone during Early-to-Mid Gestation.
    Abbott DH; Vepraskas SH; Horton TH; Terasawa E; Levine JE
    Neuroendocrinology; 2018; 107(2):133-146. PubMed ID: 29949806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.